Marijuana use in opioid exposed pregnancy increases risk of preterm birth

References

• Haight SC, Ko JY, Tong VT, et al. Opioid use disorder documented at delivery hospitalization–United States, 1999–2014. MMWR Morb Mortal Wkly Rep. 2018;67(31):845–849.
   PubMed Web of Science ®Google Scholar
• ACOG Committee opinion, Number 711, August 2017. Committee on Obstetric Practice, American Society of Addiction Medicine.
   Google Scholar
• Baer RJ, Chambers CD, Ryckman KK, et al. Risk of preterm and early term birth by maternal drug use. J Perinatol. 2019;39(2):286–294.
   PubMed Web of Science ®Google Scholar
• Azuine RE, Ji Y, Chang HY, et al. Prenatal risk factors and perinatal and postnatal outcomes associated with maternal opioid exposure in an urban, low-income, multiethnic US population. JAMA Netw Open. 2019;2(6):e196405.
   PubMed Web of Science ®Google Scholar
• Lemon LS, Naimi A, Caritis SN, et al. The role of preterm birth in association between opioid maintenance therapy and neonatal abstinence syndrome. Paediatr Perinat Epidemiol. 2018;32(2):213–222. PMD 29372750
   PubMed Web of Science ®Google Scholar
• Norgaard M, Nielsson MS, Jorgensen UH. Birth and neonatal outcomes following opioid use in pregnancy; a Danish population study. Subst Abuse; Res Treat. 2015;9(S2):5–11.
   PubMedGoogle Scholar
• Jumah NA. Rural, pregnant, and opioid dependent: a systematic review. Subst Abuse. 2016;10 (Suppl 1):35–41. SART–34547
   PubMedGoogle Scholar
• Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. 2017. National Survey on Drug Use and Health: Annual National Report. https://www.samhsa.gov/data/report/2017-nsduh-annual-national-report. Retrieved January. 14, 2020.
   Google Scholar
• ACOG Committee on Health Care for Underserved Women. ACOG Committee opinion no. 524: opioid abuse, dependence, and addiction in pregnancy. Obstet Gynecol. 2012;119:1070–1076.
   PubMedGoogle Scholar
• Dickson B, Mansfield C, Guiah M, et al. Recommendation from cannabis dispensaries about first trimester cannabis use. Obstet Gynecol. 2018;131(6):1031–1038.
   PubMed Web of Science ®Google Scholar
• Young-Wolf KC, Sarovar V, Tucker LY, et al. Association of nausea and vomiting in pregnancy with prenatal marijuana use. JAMA Intern Med. 2018;178(10):1423–1424.
   PubMed Web of Science ®Google Scholar
• van Gelder MM, Reefhuis J, Caton AR, National Birth Defects Prevention Study, et al. Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study. Drug Alcohol Depend. 2010;109(1–3):243–247.
   PubMed Web of Science ®Google Scholar
• Gunn JK, Rosales CB, Center KE, et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open. 2016;6(4):e009986.
   PubMed Web of Science ®Google Scholar
• Janisse JJ, Bailey BA, Ager J, et al. Alcohol, tobacco, cocaine, and marijuana use: relative contributions to preterm delivery and fetal growth restriction. Subst Abuse. 2014;35(1):60–67.
   PubMed Web of Science ®Google Scholar
• Gray TR, Eiden RD, Leonard KE, et al. Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clin Chem. 2010;56(9):1442–1450.
   PubMed Web of Science ®Google Scholar
• Saurel‐Cubizolles MJ, Prunet C, Blondel B. Cannabis use during pregnancy in France in 2010. BJOG. 2014;121(8):971–977.
   PubMed Web of Science ®Google Scholar
• Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013;13(1):59.
   PubMed Web of Science ®Google Scholar
• Martin PR, Finlayson AR. Opioid use disorder during pregnancy in Tennessee: expediency vs. science. Am J Drug Alcohol Abuse. 2015;41(5):367–370.
   PubMed Web of Science ®Google Scholar
• O'Connor AB, Kelly BK, O'Brien LM. Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine. Drug Alcohol Depend. 2017;180:200–203.
   PubMed Web of Science ®Google Scholar
• Bada HS, Das A, Bauer CR, et al. Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure. J Perinatol. 2005;25(10):631–637.
   PubMedGoogle Scholar
• Dekker GA, Lee SY, North RA, et al. Risk factors for preterm birth in an international prospective cohort of nulliparous women. PLoS One. 2012;7(7):e39154.
   PubMed Web of Science ®Google Scholar
• Gibson GT, Baghurst PA, Colley DP. Maternal alcohol, tobacco and cannabis consumption and the outcome of pregnancy. Aust N Z J Obstet Gynaecol. 1983;23(1):15–19.
   PubMed Web of Science ®Google Scholar
• Fergusson DM, Horwood LJ, Northstone K, ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Maternal use of cannabis and pregnancy outcome. BJOG. 2002;109(1):21–27.
   PubMed Web of Science ®Google Scholar
• Metz TD, Stickrath EH. Marijuana use in pregnancy and lactation: a review of the evidence. Am J Obstet Gynecol. 2015;213(6):761–778.
   PubMed Web of Science ®Google Scholar
• Jansson LM, Jordan CJ, Velez ML. Perinatal marijuana use and the developing child. JAMA. 2018;320(6):545–546.
   PubMed Web of Science ®Google Scholar
• Conner SN, Bedell V, Lipsey K, et al. Maternal marijuana use and adverse neonatal outcomes: a systematic review and meta-analysis. Obstet Gynecol. 2016;128(4):713–723.
   PubMed Web of Science ®Google Scholar
• Hatch EE, Bracken MB. Effect of marijuana use in pregnancy on fetal growth. Am J Epidemiol. 1986;124(6):986–993.
   PubMed Web of Science ®Google Scholar
• Schneider M. Cannabis use in pregnancy and early life and its consequences: animal models. Eur Arch Psychiatry Clin Neurosci. 2009;259(7):383–393.
   PubMed Web of Science ®Google Scholar
• DiNieri JA, Wang X, Szutorisz H, et al. Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. Biol Psychiatry. 2011;70(8):763–769.
   PubMed Web of Science ®Google Scholar
• Jutras-Aswad D, DiNieri JA, Harkany T, et al. Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome. Eur Arch Psychiatry Clin Neurosci. 2009;259(7):395–412.
   PubMed Web of Science ®Google Scholar
• Wang X, Dow-Edwards D, Anderson V, et al. Discrete opioid gene expression impairment in the human fetal brain associated with maternal marijuana use. Pharmacogenomics J. 2006;6(4):255–264.
   PubMed Web of Science ®Google Scholar
• Maia J, Almada M, Midão L, et al. The cannabinoid Delta-9-tetrahydrocannabinol disrupts estrogen signaling in human placenta. Toxicol Sci. 2020;177(2):420–430.
   PubMed Web of Science ®Google Scholar
• Holland CL, Rubio D, Rodriguez KL, et al. Obstetric health care providers' counseling responses to pregnant patient disclosures of marijuana use. Obstet Gynecol. 2016;127(4):681–687.
   PubMed Web of Science ®Google Scholar
• Holland CL, Nkumsah MA, Morrison P, et al. "Anything above marijuana takes priority": obstetric providers' attitudes and counseling strategies regarding perinatal marijuana use. Patient Educ Couns. 2016;99(9):1446–1451.
   PubMed Web of Science ®Google Scholar